These independent findings from the Stingele group support the relevance of our results at the cellular level, indicating that the USD, and likely the stimulation of SPRTN proteolysis by ubiquitin chains, are essential for protecting against genomic instability in RJALS patients. The gene discussed is SPRTN; the disease is progeroid features-hepatocellular carcinoma predisposition syndrome.